Zac1 regulates IL-11 expression in osteoarthritis
Open Access
- 21 August 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (65) , 32478-32495
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Chun-Lin Kuo1, 2, Shu-Ting Liu3, Yung-Lung Chang3, Chia-Chun Wu2 and Shih-Ming Huang1, 3 1Graduate Institute of Medical Sciences, National Defense Medical Center, Taiwan, Republic of China 2Department of Orthopaedic Surgery, Tri-Service General Hospital, National Defense Medical Center, Taiwan, Republic of China 3Department of Biochemistry, National Defense Medical Center, Taiwan, Republic of China Correspondence to: Shih-Ming Huang, email: shihming@ndmctsgh.edu.tw Keywords: zac1; IL-11; HeLa; osteoarthritis; IL-6 Received: March 30, 2018 Accepted: July 29, 2018 Published: August 21, 2018 ABSTRACT Interleukin (IL)-11, a member of the IL-6 family of cytokines, exerts pleiotropic effects under normal and various disease conditions. We assessed IL-11 expression regulation and the IL-11/IL-6 ratio in osteoarthritis (OA) to better guide clinical therapeutic decision-making. Our findings suggest that Zac1, a zinc finger protein that regulates apoptosis and cell cycle arrest, is a transcription factor regulating IL-11 expression. Zac1 overexpression or knockdown respectively induced or suppressed IL-11 expression in HeLa cells. Zac1 acted synergistically with AP-1, human papillomavirus E2, and hypoxia inducible factor 1 alpha (HIF1α). IL-11 expression under various conditions, including hypoxia or treatment with phorbol 12-myristate 13-acetate or copper sulfate. Recombinant IL-11-induced phosphorylation of signal transducer and activator of transcription 3 at tyrosine 705 was reduced in a dose-dependent manner in HeLa cells. Cross-talk between Zac1, IL-11, p53, and suppressor of cytokine signaling 3 was differentially affected by copper sulfate, digoxin, and caffeine. Finally, aggressive vs. conventional treatment of OA patients was primarily determined by IL-6 levels. However, we suggest that OA patients with higher IL-11 levels may respond well to conventional treatments, even in the presence of high IL-6.Keywords
This publication has 64 references indexed in Scilit:
- Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cellsJournal of Clinical Investigation, 2013
- Constitutively Active Mutant gp130 Receptor Protein from Inflammatory Hepatocellular Adenoma Is Inhibited by an Anti-gp130 Antibody That Specifically Neutralizes Interleukin 11 SignalingJournal of Biological Chemistry, 2012
- Vanilloid Receptor-1 Regulates Neurogenic Inflammation in Colon and Protects Mice from Colon CancerCancer Research, 2012
- Interleukin-11 Promotes the Progress of Gastric Carcinoma via Abnormally Expressed VersicanInternational Journal of Biological Sciences, 2012
- Zac1 is a histone acetylation-regulated NF-κB suppressor that mediates histone deacetylase inhibitor-induced apoptosisCell Death & Differentiation, 2011
- Mechanical Stress Activates Smad Pathway through PKCδ to Enhance Interleukin-11 Gene Transcription in OsteoblastsPLOS ONE, 2010
- Regulation of Cardiomyocyte Glut4 Expression by ZAC1Journal of Biological Chemistry, 2010
- STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant miceJournal of Clinical Investigation, 2008
- Importin α1 is involved in the nuclear localization of Zac1 and the induction of p21WAF1/CIP1 by Zac1Biochemical Journal, 2007
- Association Analysis of Single Nucleotide Polymorphisms in Cartilage-Specific Collagen Genes With Knee and Hip Osteoarthritis in the Japanese PopulationJournal of Bone and Mineral Research, 2002